{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:36:19Z","timestamp":1777869379167,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00108-026-02104-6","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:52:43Z","timestamp":1774619563000},"page":"493-498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vorgehen bei Verdacht auf eine Glomerulonephritis","Approach to suspected glomerulonephritis"],"prefix":"10.1007","volume":"67","author":[{"given":"Laura Katharina","family":"Sievers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"4","key":"2104_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin\u00a0BH, Adler\u00a0SG, Barratt\u00a0J et\u00a0al (2021) KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney International 100(4):S1\u2013S276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021","journal-title":"Kidney International"},{"issue":"1","key":"2104_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1517\/14740338.5.1.95","volume":"5","author":"H Izzedine","year":"2006","unstructured":"Izzedine\u00a0H, Launay-Vacher\u00a0V, Bourry\u00a0E, Brocheriou\u00a0I, Karie\u00a0S, Deray\u00a0G (2006) Drug-induced glomerulopathies. Expert Opinion on Drug Safety 5(1):95\u2013106. https:\/\/doi.org\/10.1517\/14740338.5.1.95","journal-title":"Expert Opinion on Drug Safety"},{"issue":"8","key":"2104_CR3","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1681\/ASN.0000000719","volume":"36","author":"RS Avasare","year":"2025","unstructured":"Avasare\u00a0RS, Andeen\u00a0NK, Al-Rabadi\u00a0LF, Burfeind\u00a0KG, Beck\u00a0LH (2025) Drug-Induced Membranous Nephropathy: Piecing Together Clues to Understand Disease Mechanisms. JASN 36(8):1629\u20131638. https:\/\/doi.org\/10.1681\/ASN.0000000719","journal-title":"JASN"},{"issue":"1","key":"2104_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41581-019-0178-8","volume":"16","author":"AA Satoskar","year":"2020","unstructured":"Satoskar\u00a0AA, Parikh\u00a0SV, Nadasdy\u00a0T (2020) Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis. Nat Rev Nephrol 16(1):32\u201350. https:\/\/doi.org\/10.1038\/s41581-019-0178-8","journal-title":"Nat Rev Nephrol"},{"key":"2104_CR5","doi-asserted-by":"publisher","DOI":"10.1159\/000546050","author":"V Royal","year":"2025","unstructured":"Royal\u00a0V, Leung\u00a0N, Karam\u00a0S, Bridoux\u00a0F, Nasr\u00a0SH (2025) Paraneoplastic Glomerulopathies: Mechanistic and Pathogenic Insights. Am J Nephrol. https:\/\/doi.org\/10.1159\/000546050","journal-title":"Am J Nephrol"},{"key":"2104_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-025-02449-5","author":"A Covic","year":"2025","unstructured":"Covic\u00a0A, Brinza\u00a0C, Burlacu\u00a0A et\u00a0al (2025) Biopsy-proven glomerular diseases: a systematic review of global kidney biopsy registries. J\u00a0Nephrol. https:\/\/doi.org\/10.1007\/s40620-025-02449-5","journal-title":"J Nephrol"},{"issue":"4","key":"2104_CR7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.kint.2025.04.003","volume":"108","author":"J Floege","year":"2025","unstructured":"Floege\u00a0J, Barratt\u00a0J, Cook\u00a0HT et\u00a0al (2025) Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV). Kidney International 108(4):548\u2013554. https:\/\/doi.org\/10.1016\/j.kint.2025.04.003","journal-title":"Kidney International"},{"issue":"2","key":"2104_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1053\/j.ajkd.2023.02.003","volume":"82","author":"LH Beck","year":"2023","unstructured":"Beck\u00a0LH, Ayoub\u00a0I, Caster\u00a0D et\u00a0al (2023) KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases. American Journal of Kidney Diseases 82(2):121\u2013175. https:\/\/doi.org\/10.1053\/j.ajkd.2023.02.003","journal-title":"American Journal of Kidney Diseases"},{"issue":"7","key":"2104_CR9","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.2215\/CJN.11261114","volume":"10","author":"MM O\u2019Shaughnessy","year":"2015","unstructured":"O\u2019Shaughnessy\u00a0MM, Montez-Rath\u00a0ME, Lafayette\u00a0RA, Winkelmayer\u00a0WC (2015) Patient Characteristics and Outcomes by GN Subtype in ESRD. Clinical Journal of the American Society of Nephrology 10(7):1170\u20131178. https:\/\/doi.org\/10.2215\/CJN.11261114","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"1","key":"2104_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41572-025-00671-w","volume":"11","author":"P Romagnani","year":"2025","unstructured":"Romagnani\u00a0P, Tang\u00a0SCW, Weins\u00a0A, Huber\u00a0TB, Osafo\u00a0C, Anders\u00a0HJ (2025) Podocytopathies. Nat Rev Dis Primers 11(1):87\u201387. https:\/\/doi.org\/10.1038\/s41572-025-00671-w","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"2104_CR11","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1056\/NEJMra020109","volume":"347","author":"JV Donadio","year":"2002","unstructured":"Donadio\u00a0JV, Grande\u00a0JP (2002) IgA Nephropathy. N\u00a0Engl J Med 347(10):738\u2013748. https:\/\/doi.org\/10.1056\/NEJMra020109","journal-title":"N Engl J Med"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02104-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-026-02104-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02104-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:38:00Z","timestamp":1777556280000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-026-02104-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2104"],"URL":"https:\/\/doi.org\/10.1007\/s00108-026-02104-6","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.K.\u00a0Sievers gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}